Narciclasine ameliorated T cell mediated acute liver injury through activating AMPK pathway

• DOI: 10.1016/j.cellimm.2022.104631
• Publication Date: 2022-10-15T02:53:14Z
• Authors: Yuanyuan Tian; Jiao Wang; Xiaori Qin; Shibing Li; Cheng Lan; Xiaoning Sun
• Keywords: Mice, Inbred C57BL; 0301 basic medicine; Mice; 03 medical and health sciences; Liver; T-Lymphocytes; Concanavalin A; Animals; Cytokines; AMP-Activated Protein Kinases; 3. Good health

Hepatitis is closely related to cirrhosis and liver cancer, and it is vital that we develop new drugs and identify new drug targets. Traditional Chinese medicine has demonstrated excellent curative effects on liver diseases. The ingredients from Chinese herbals are important source for drug development in the treatment of hepatitis. Here, we found that narciclasine (NCS), a major component extracted from narcissus bulbs, showed hepatoprotective effect against concanavalin A (Con A) induced hepatitis. NCS treatment significantly reduced hepatocyte death, hepatic inflammatory cells infiltration, and serum cytokine levels in Con A challenged mice. We further observed that NCS directly inhibited Con A induced splenocytes proliferation and cytokine production in vitro. RNA-seq results showed that genes related to immune response were upregulated in Con A treated CD4+ T cells, which were down-regulated in the presence of NCS. Moreover, the AMPK pathway had been found activated in response to NCS treatment, suggesting a potential target for NCS targets. In conclusion, our results reveal that NCS is a powerful immunosuppressor against T cell activation, thus leading to protection against Con A induced liver injury in mice. These findings provide new insights into the use of natural products in the treatment of autoimmune hepatitis.